dup 697 has been researched along with lenvatinib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Altun, A; Kaya, TT; Turgut, NH | 1 |
1 other study(ies) available for dup 697 and lenvatinib
Article | Year |
---|---|
Anticancer effect of COX-2 inhibitor DuP-697 alone and in combination with tyrosine kinase inhibitor (E7080) on colon cancer cell lines.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chick Embryo; Chorioallantoic Membrane; Colonic Neoplasms; Cyclooxygenase 2 Inhibitors; HT29 Cells; Humans; Neovascularization, Pathologic; Phenylurea Compounds; Protein-Tyrosine Kinases; Quinolines; Thiophenes | 2014 |